238 related articles for article (PubMed ID: 37383232)
1. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
Li Y; Jia Y
Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Chen L; Su T; Liu Y
BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.
Zlotnik Y; Gadoth A; Abu-Salameh I; Horev A; Novoa R; Ifergane G
Front Immunol; 2021; 12():813487. PubMed ID: 35069602
[TBL] [Abstract][Full Text] [Related]
5. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis.
Qiao T; Chen L; Jiang L; Wei H; Chen X; Li X; Chen Y; Xu Y
Front Immunol; 2022; 13():986853. PubMed ID: 36211373
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Paroxysmal weakness of unilateral limb as an initial symptom in anti-LGI1 encephalitis: a report of five cases.
Wang S; Wang J; Li B; Hu N; Jin Y; Han S; Shang X
Front Immunol; 2023; 14():1191823. PubMed ID: 37304289
[TBL] [Abstract][Full Text] [Related]
8. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
9. Recognizing New-Onset Sleep Disorders in Autoimmune Encephalitis Often Prompt Earlier Diagnosis.
Ralls F; Cutchen L; Grigg-Damberger MM
J Clin Neurophysiol; 2022 Jul; 39(5):363-371. PubMed ID: 35239557
[TBL] [Abstract][Full Text] [Related]
10. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
[TBL] [Abstract][Full Text] [Related]
11. Anti-LGI1 Encephalitis With Co-occurring IgLON5 Antibodies: Clinical Features and Human Leukocyte Antigen Haplotypes.
Schiff P; Muñiz-Castrillo S; Do LD; Fantini ML; Chanson E; Rogemond V; Honnorat J; Poncet-Megemont L
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37217310
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
Chung HY; Wickel J; Voss A; Ceanga M; Sell J; Witte OW; Geis C
Medicine (Baltimore); 2019 May; 98(20):e15706. PubMed ID: 31096519
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
[TBL] [Abstract][Full Text] [Related]
14. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature.
Kong DL
World J Clin Cases; 2023 Jan; 11(2):408-416. PubMed ID: 36686352
[TBL] [Abstract][Full Text] [Related]
15. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
16. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
Yang J; Sun Q; Yang G
Front Neurol; 2020; 11():61. PubMed ID: 32153488
[TBL] [Abstract][Full Text] [Related]
17. Anti-Leucine-rich glioma-inactivated Protein 1 antibody-associated encephalitis complicated by minimal change nephrotic syndrome: a case report.
Zhang WJ; Gao N
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7556-7560. PubMed ID: 36314326
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
19. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
20. Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis.
Mo J; Dong W; Cui T; Chen C; Shi W; Hu W; Zhang C; Wang X; Zhang K; Shao X
Eur J Neurol; 2022 Aug; 29(8):2376-2385. PubMed ID: 35514068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]